Increased injection site pain, burning sensations, or unusual resistance during injection could indicate solution degradation or contamination
Existing reproductive medicine literature often relies on theoretical extrapolationssuch as the assumption that weight loss inherently restores ovulationbut lacks systematic evaluations of hard reproductive endpoints, including natural pregnancy rates, time to pregnancy (TTP), and cumulative live birth rates in ART ( 1.4.3 Real-world decision dilemmas The friction between prevalent clinical use and existing defensive guidelines is particularly salient in the following three scenarios: Value assessment of pretreatment before ART: in obese PCOS patients with IR or MASLD, GLP-1RAs are frequently utilized as weight-loss accelerators before starting stimulation cycles
Orforglipron works slightly differently to GLP-1 injections
Common side effects (may affect up to 1 in 10 people): * Pain, redness, or swelling at the injection site * Nausea * Headache Uncommon side effects (may affect up to 1 in 100 people): * Diarrhea * Dizziness * Allergic reactions such as skin rash, itching, or hives Rare side effects (may affect up to 1 in 1,000 people): * Severe allergic reaction (anaphylaxis) with symptoms like difficulty breathing, swelling of the face or throat, and a drop in blood pressure
